Decoy Therapeutics
DCOY
4 hedge funds and large institutions have $81.9M invested in Decoy Therapeutics in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
12% more capital invested
Capital invested by funds: $73.4M → $81.9M (+$8.53M)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$10.5M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$156K |
| 3 |
A
Abingworth
London,
United Kingdom
|
-$120K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3K |
DCOY Hedge Fund Activity: Q4 2015 in Review
4 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Decoy Therapeutics (DCOY) for Q4 2015, worth a combined $81.9M — up 12% from $73.4M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DCOY and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Capital World Investors, exiting entirely with an estimated $10.5M sold.
- 4 institutional investors held Decoy Therapeutics (DCOY) as of Q4 2015, down from 5 in Q3 2015.
- Funds reported $81.9M of Decoy Therapeutics stock for Q4 2015, up 12% quarter-over-quarter.
- 0 funds opened new Decoy Therapeutics positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest Decoy Therapeutics seller in Q4 2015 was Capital World Investors, an estimated $10.5M sold.
Based on aggregated 13F filings for Q4 2015.